Literature DB >> 24366752

A conformational restriction in the influenza A virus neuraminidase binding site by R152 results in a combinational effect of I222T and H274Y on oseltamivir resistance.

Lan Huang1, Yang Cao, Jianfang Zhou, Kun Qin, Wenfei Zhu, Yun Zhu, Lei Yang, Dayan Wang, Hong Wei, Yuelong Shu.   

Abstract

The I222K, I222R, and I222T substitutions in neuraminidase (NA) have been found in clinically derived 2009 pandemic influenza A/H1N1 viruses with altered susceptibilities to NA inhibitors (NAIs). The effects of these substitutions, together with the most frequently observed resistance-related substitution, H274Y, on viral fitness and resistance mechanisms were further investigated in this study. Reduced sensitivities to oseltamivir were observed in all three mutants (I222K, I222R, and I222T). Furthermore, the I222K and I222T substitutions had a combinational effect of further increasing resistance in the presence of H274Y, which might result from a conformational restriction in the NA binding site. Of note, by using molecular dynamics simulations, R152, the neighbor of T222, was observed to translate to a position closer to T222, resulting in the narrowing of the binding pocket, which otherwise only subtends the residue substitution of H274Y. Moreover, significantly attenuated NA function and viral growth abilities were found in the I222K+H274Y double mutant, while the I222T+H274Y double mutant exhibited slightly delayed growth but had a peak viral titer similar to that of the wild-type virus in MDCK cells. The relative growth advantage of the I222T mutant versus the I222K mutant and the higher frequency of I222T emerging in N1 subtype influenza viruses raise concerns necessitating close monitoring of the dual substitutions I222T and H274Y.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24366752      PMCID: PMC3957868          DOI: 10.1128/AAC.01848-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivir.

Authors:  Ha T Nguyen; Alicia M Fry; P Ann Loveless; Alexander I Klimov; Larisa V Gubareva
Journal:  Clin Infect Dis       Date:  2010-10-15       Impact factor: 9.079

2.  Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.

Authors:  Andrés Pizzorno; Xavier Bouhy; Yacine Abed; Guy Boivin
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

3.  Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.

Authors:  Erhard van der Vries; Foekje F Stelma; Charles A B Boucher
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

4.  Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses.

Authors:  Hui-Ling Yen; Erich Hoffmann; Garry Taylor; Christoph Scholtissek; Arnold S Monto; Robert G Webster; Elena A Govorkova
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses.

Authors:  Aeron C Hurt; Jessica K Holien; Ian G Barr
Journal:  Antimicrob Agents Chemother       Date:  2009-08-03       Impact factor: 5.191

6.  The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.

Authors:  Debra Birnkrant; Edward Cox
Journal:  N Engl J Med       Date:  2009-11-02       Impact factor: 91.245

7.  SwissParam: a fast force field generation tool for small organic molecules.

Authors:  Vincent Zoete; Michel A Cuendet; Aurélien Grosdidier; Olivier Michielin
Journal:  J Comput Chem       Date:  2011-05-03       Impact factor: 3.376

8.  Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.

Authors:  Jesse D Bloom; Lizhi Ian Gong; David Baltimore
Journal:  Science       Date:  2010-06-04       Impact factor: 47.728

9.  Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir.

Authors:  Mathilde Richard; Olivier Ferraris; Alexandra Erny; Mendy Barthélémy; Aurélien Traversier; Murielle Sabatier; Alan Hay; Yi Pu Lin; Rupert J Russell; Bruno Lina
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

10.  A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.

Authors:  Yoko Matsuzaki; Katsumi Mizuta; Yoko Aoki; Asuka Suto; Chieko Abiko; Kanako Sanjoh; Kanetsu Sugawara; Emi Takashita; Tsutomu Itagaki; Yuriko Katsushima; Makoto Ujike; Masatsugu Obuchi; Takato Odagiri; Masato Tashiro
Journal:  Virol J       Date:  2010-03-05       Impact factor: 4.099

View more
  9 in total

1.  Molecular surveillance of antiviral drug resistance of influenza A/H3N2 virus in Singapore, 2009-2013.

Authors:  Hong Kai Lee; Julian Wei-Tze Tang; Tze Ping Loh; Aeron C Hurt; Lynette Lin-Ean Oon; Evelyn Siew-Chuan Koay
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

2.  Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice.

Authors:  Andrés Pizzorno; Yacine Abed; Pier-Luc Plante; Julie Carbonneau; Mariana Baz; Marie-Ève Hamelin; Jacques Corbeil; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

3.  Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.

Authors:  Yasushi Itoh; Shintaro Shichinohe; Misako Nakayama; Manabu Igarashi; Akihiro Ishii; Hirohito Ishigaki; Hideaki Ishida; Naoko Kitagawa; Takako Sasamura; Masanori Shiohara; Michiko Doi; Hideaki Tsuchiya; Shinichiro Nakamura; Masatoshi Okamatsu; Yoshihiro Sakoda; Hiroshi Kida; Kazumasa Ogasawara
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

4.  Oseltamivir-resistant influenza A (H1N1) virus strain with an H274Y mutation in neuraminidase persists without drug pressure in infected mallards.

Authors:  Anna Gillman; Shaman Muradrasoli; Hanna Söderström; Fredrik Holmberg; Neus Latorre-Margalef; Conny Tolf; Jonas Waldenström; Gunnar Gunnarsson; Björn Olsen; Josef D Järhult
Journal:  Appl Environ Microbiol       Date:  2015-01-23       Impact factor: 4.792

5.  The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir.

Authors:  Angela M Phillips; Matthew D Shoulders
Journal:  J Mol Biol       Date:  2015-12-31       Impact factor: 5.469

6.  Influenza A(H7N9) virus acquires resistance-related neuraminidase I222T substitution when infected mallards are exposed to low levels of oseltamivir in water.

Authors:  Anna Gillman; Marie Nykvist; Shaman Muradrasoli; Hanna Söderström; Michelle Wille; Annika Daggfeldt; Caroline Bröjer; Jonas Waldenström; Björn Olsen; Josef D Järhult
Journal:  Antimicrob Agents Chemother       Date:  2015-06-15       Impact factor: 5.191

Review 7.  Drug resistance in influenza A virus: the epidemiology and management.

Authors:  Mazhar Hussain; Henry D Galvin; Tatt Y Haw; Ashley N Nutsford; Matloob Husain
Journal:  Infect Drug Resist       Date:  2017-04-20       Impact factor: 4.003

8.  Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.

Authors:  Ashona Singh; Mahmoud E Soliman
Journal:  Drug Des Devel Ther       Date:  2015-07-31       Impact factor: 4.162

9.  Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus.

Authors:  Jana Pokorná; Petr Pachl; Elena Karlukova; Jakub Hejdánek; Pavlína Řezáčová; Aleš Machara; Jason Hudlický; Jan Konvalinka; Milan Kožíšek
Journal:  Viruses       Date:  2018-06-21       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.